magnesium sulfate has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, L; Lin, R; Wu, B; Yan, M; Zheng, Z | 1 |
| Chassain, C; Durif, F; Eschalier, A | 1 |
2 other study(ies) available for magnesium sulfate and Parkinsonian Disorders
| Article | Year |
|---|---|
Expression of magnesium transporter SLC41A1 in the striatum of 6-hydroxydopamine-induced parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Cation Transport Proteins; Corpus Striatum; Dopamine Agonists; Dopaminergic Neurons; Gene Expression; Magnesium; Magnesium Sulfate; Male; Movement; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; RNA, Messenger; Tyrosine 3-Monooxygenase | 2018 |
Antidyskinetic effect of magnesium sulfate in MPTP-lesioned monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca mulatta; Magnesium Sulfate; Motor Activity; Parkinsonian Disorders | 2003 |